𝔖 Bobbio Scriptorium
✦   LIBER   ✦

mRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers

✍ Scribed by Y. Kanai; S. Ushijima; Y. Saito; Y. Nakanishi; M. Sakamoto; S. Hirohashi


Publisher
Springer-Verlag
Year
2001
Tongue
English
Weight
185 KB
Volume
127
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Induction of tubulin by docetaxel is ass
✍ Jinghua Tsai Chang; Gee-Chen Chang; Jiunn-Liang Ko; Hung-Ya Liao; Hsin-Ju Liu; C πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 408 KB πŸ‘ 1 views

Docetaxel (DOC), a member of the taxane family of anticancer drugs, binds to tubulin and produces unnaturally stable microtubules that induce cell death. DOC is used clinically alone or in combination with other compounds to treat advanced stages of cancer. We have treated the human lung cancer cell

Abrogation of apoptosis induced by DNA-d
✍ Takashi Kawasaki; Yoshihiko Tomita; Vladimir Bilim; Masayuki Takeda; Kota Takaha πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 570 KB

The p53-inducible cyclin-dependent kinase inhibitor, p2 I / WAFI/CIPI (p2I), plays a pivotal role in the GI arrest or apoptosis of cells expored to genotoxic stimuli. To determine whether p2 I is a putative tumor-suppressor gene, p2 I status was investigated in 4 human bladder-cancer cell lines of k

Acquired cisplatin resistance in the hea
✍ Eva M. Gosepath; Niels Eckstein; Alexandra Hamacher; Kati Servan; Georg von Jonq πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 French βš– 301 KB πŸ‘ 1 views

## Abstract Head and neck cancers are treated by a combination of surgery, radiotherapy and/or chemotherapy. The clinical success of cisplatin‐based chemotherapy, mostly in combination with 5‐FU or a taxane, is however limited by multifactorial intrinsic or acquired resistance. So far, known genes